Sunagahalli Jayaram Ashok

Sunagahalli Jayaram Ashok

Active Director Director DIN 03157115
DIN 03157115 First appointment Aug 2010 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Aug 2010
Shareholding value •••• Premium profile

About Sunagahalli Jayaram Ashok

Data last updated:

Sunagahalli Jayaram Ashok is a Director at Mandya Multi Speciality Hospital Private Limited (since 2025), Director at Belaku Eye Hospitals Private Limited (since 2010) and Director at Arn Infra Mart Private Limited (since 2024). The companies operate in Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹25.07 Cr; the largest is Mandya Multi Speciality Hospital Private Limited at ₹18.81 Cr (FY 2025). Earlier, Sunagahalli Jayaram Ashok was a Director at Bel-Cross Mining Private Limited (from 2015).

DIN 03157115
Primary Designation Director
Industry Healthcare
First Appointment 16 Aug 2010
Oldest Company Age 16 yrs
Largest company Mandya Multi Speciality Hospital Private Limited · ₹18.81 Cr (FY 2025)
Combined revenue ₹25.07 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Sep 20252021₹18.81 Cr (FY 2025)Active
Belaku Eye Hospitals Private Limited U85110KA2010PTC054798
Director16 Aug 20102010₹6.26 Cr (FY 2025)Active
Arn Infra Mart Private Limited U47521KA2024PTC188457
Director13 May 20242024Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bel-Cross Mining Private Limited U14292KA2015PTC078774
Director09 Feb 20152015Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Bel-Cross Mining Private Limited
Belaku Eye Hospitals Private Limited
Mandya Multi Speciality Hospital Private Limited
Arn Infra Mart Private Limited
Premium access

Shareholding and investment profile for Sunagahalli Jayaram Ashok

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunagahalli Jayaram Ashok

Sunagahalli Jayaram Ashok currently holds 3 directorships: Mandya Multi Speciality Hospital Private Limited (Director, since 30 Sep 2025, revenue ₹18.81 Cr (FY 2025)); Belaku Eye Hospitals Private Limited (Director, since 16 Aug 2010, revenue ₹6.26 Cr (FY 2025)); Arn Infra Mart Private Limited (Director, since 13 May 2024).

Sunagahalli Jayaram Ashok was first appointed on 16 Aug 2010 as Director at Belaku Eye Hospitals Private Limited. The most recent appointment on record is 30 Sep 2025 at Mandya Multi Speciality Hospital Private Limited.

The 2 current companies of Sunagahalli Jayaram Ashok that report revenue have a combined latest revenue of ₹25.07 Cr: Mandya Multi Speciality Hospital Private Limited ₹18.81 Cr (FY 2025); Belaku Eye Hospitals Private Limited ₹6.26 Cr (FY 2025).

Sunagahalli Jayaram Ashok held 1 earlier board appointment: Bel-Cross Mining Private Limited (Director, from 09 Feb 2015).

The current boards of Sunagahalli Jayaram Ashok's companies include Asif S Khan (Mandya Multi Speciality Hospital Private Limited), Induval Chandrashekhar Adityagowda (Mandya Multi Speciality Hospital Private Limited), Iqbal Ahmed (Mandya Multi Speciality Hospital Private Limited), Kommi Ravindranath (Mandya Multi Speciality Hospital Private Limited), Anitha Boregowda (Belaku Eye Hospitals Private Limited), Suresh Hanumanthaiah Honnamachanalli (Belaku Eye Hospitals Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available